Search

everythinglearnresearchcommunity

for

Search:↓

Most dogs with alopecia had higher than normal levels of certain hormones, but hair loss might not always be linked to these hormone changes.

Sex hormones likely don't affect atopic dermatitis in adolescents and adults.

Women with a certain type of tumor had higher levels of pregnancy hormone and male hormones, which decreased after treatment.

High afamin levels are linked to metabolic syndrome and may predict its development in women with insulin resistance.

Loose anagen hair syndrome, often affecting young girls, can be diagnosed with a hair-pull test and usually gets better on its own, but severe cases may need treatment.

The cause of atypical Cushing's syndrome in dogs, possibly linked to sex hormones, is not yet proven.

Rosiglitazone may be better than metformin for insulin resistance in PCOS, but more research is needed on certain biomarkers.

Chesapeake Bay retrievers' hair loss is likely a breed-specific, hereditary condition linked to abnormal steroid levels and distinct skin changes.

Blood tests for tumor cells could improve prostate cancer diagnosis and treatment; hair loss severity linked to a gene affecting prostate conditions.

Chemicals and body size might change when puberty starts and progresses, but more research is needed to confirm this.

A woman was diagnosed with Sheehan's syndrome and a rare complication of diabetes insipidus 33 years after symptoms began, improving with hormone therapy.

Most lab tests for patients with Telogen effluvium, a type of hair loss, show no or mild abnormalities; only a few specific tests are useful.

New genotype linked to non-classical congenital adrenal hyperplasia found in Italian siblings.

Many patients with hair loss had low iron and vitamin D levels, but thyroid issues were not common.

Hormone therapy with estradiol and spironolactone can regrow scalp hair in transgender women by lowering testosterone to female levels.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Testosterone therapy seems safe and effective for transgender men with proper care, but more long-term research is needed.

Androgen therapy can help with symptoms like low libido in women, but more research is needed to understand its long-term safety and effects on health.

Women with PCOS who have low SHBG are more likely to have low good cholesterol and metabolic syndrome.

SHBG may be a useful early indicator and treatment target for PCOS.

Parathyroid hormone-related protein helps control hair growth phases in mice.

People with hair loss have higher risk of high blood sugar and diabetes, and lower levels of a specific hormone.

PTHrP and its receptor can control blood vessel growth and hair development in mouse skin.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Anti-Müllerian hormone is a specific marker for ovarian issues in women with conditions like PCOS.

PTHRP agonists can stimulate hair growth, especially in damaged follicles, while antagonists may initially increase growth but ultimately inhibit it.

Thyroid function may influence hair loss after COVID-19.

Certain gene variations in AKT2 are more common in women with PCOS and are linked to higher levels of specific hormones and symptoms.

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

Injecting alpha-melanocyte-stimulating hormone in mice improved skin healing and reduced scarring.